As others have already pointed out, "designing around" is a major cost of IP in general. If you focus on the pharma industry, you may want to check out one chapter from Levine and Boldrin's book . It talks about how, strangely, the pharmaceutic industry innovated vigorosly even without patent protection. Or how a big market in cheap generic